Literature DB >> 19064716

Role of ASC in the mouse model of Helicobacter pylori infection.

Bekale N Benoit1, Motohiro Kobayashi, Masatomo Kawakubo, Michiko Takeoka, Kenji Sano, Jian Zou, Naoki Itano, Hiroko Tsutsui, Tetsuo Noda, Minoru Fukuda, Jun Nakayama, Shun'ichiro Taniguchi.   

Abstract

Apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain (ASC) is an adaptor molecule activating caspase-1 that stimulates pro-interleukin-1beta (pro-IL-1beta) and pro-IL-18, two pro-inflammatory cytokines with critical functions in host defense against a variety of pathogens. In this study, we investigated the role of ASC in the host defense against Helicobacter pylori utilizing ASC-deficient mice. Mice were orally inoculated with H. pylori; bacterial load, degree of gastritis, and mucosal levels of inflammatory cytokines were analyzed and compared with those obtained from wild-type mice. We found more prominent H. pylori colonization in ASC-deficient mice, as revealed by colony-forming unit counts. Both groups of mice developed gastritis; however, ASC-deficient mice showed significant attenuation of inflammation despite high H. pylori colonization. ELISA, immunohistochemistry, and quantitative RT-PCR analyses revealed complete suppression of IL-1beta and IL-18, and substantial reduction of interferon-gamma (IFN-gamma) expression, in ASC-deficient mice without apparent upregulation of other cytokines, including IL-10 and tumor necrosis factor-alpha. These results as a whole indicate that ASC exerts considerable influence on the host defense, acting through IL-1beta/IL-18 and subsequent IFN-gamma production, which in turn contributes to continuous chronic inflammatory response and consequent reduction of H. pylori colonization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064716      PMCID: PMC2664985          DOI: 10.1369/jhc.2008.952366

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  47 in total

1.  ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells.

Authors:  J Masumoto; S Taniguchi; K Ayukawa; H Sarvotham; T Kishino; N Niikawa; E Hidaka; T Katsuyama; T Higuchi; J Sagara
Journal:  J Biol Chem       Date:  1999-11-26       Impact factor: 5.157

2.  Antitumor activity of interleukin-18 on mouse glioma cells.

Authors:  T Kikuchi; Y Akasaki; T Joki; T Abe; M Kurimoto; T Ohno
Journal:  J Immunother       Date:  2000 Mar-Apr       Impact factor: 4.456

3.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

4.  Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy.

Authors:  J G Fox; P Beck; C A Dangler; M T Whary; T C Wang; H N Shi; C Nagler-Anderson
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

5.  A small animal model of human Helicobacter pylori active chronic gastritis.

Authors:  A Lee; J G Fox; G Otto; J Murphy
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

6.  Helicobacter pylori infection in interleukin-4-deficient and transgenic mice.

Authors:  W Chen; D Shu; V S Chadwick
Journal:  Scand J Gastroenterol       Date:  1999-10       Impact factor: 2.423

Review 7.  Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer.

Authors:  P Sipponen; H Hyvärinen
Journal:  Scand J Gastroenterol Suppl       Date:  1993

Review 8.  Helicobacter pylori and gastric carcinogenesis.

Authors:  P Correa
Journal:  Am J Surg Pathol       Date:  1995       Impact factor: 6.394

9.  Regulation of IL-18 in Helicobacter pylori infection.

Authors:  Kazuyoshi Yamauchi; Il-Ju Choi; Hong Lu; Hiroaki Ogiwara; David Y Graham; Yoshio Yamaoka
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

10.  Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk.

Authors:  M J Blaser; P H Chyou; A Nomura
Journal:  Cancer Res       Date:  1995-02-01       Impact factor: 12.701

View more
  6 in total

Review 1.  Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori.

Authors:  Nina R Salama; Mara L Hartung; Anne Müller
Journal:  Nat Rev Microbiol       Date:  2013-05-08       Impact factor: 60.633

2.  Cloning of Helicobacter suis cholesterol α-glucosyltransferase and production of an antibody capable of detecting it in formalin-fixed, paraffin-embedded gastric tissue sections.

Authors:  Masatomo Kawakubo; Kazuki Horiuchi; Hitomi Komura; Yoshiko Sato; Masayoshi Kato; Meguru Ikeyama; Mana Fukushima; Shigenori Yamada; Satoshi Ishizone; Takehisa Matsumoto; Hiroyoshi Ota; Junji Sagara; Jun Nakayama
Journal:  Histochem Cell Biol       Date:  2017-05-22       Impact factor: 4.304

Review 3.  Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis.

Authors:  Barbara Kronsteiner; Josep Bassaganya-Riera; Casandra Philipson; Monica Viladomiu; Adria Carbo; Vida Abedi; Raquel Hontecillas
Journal:  Gut Microbes       Date:  2016

4.  Cholestenone functions as an antibiotic against Helicobacter pylori by inhibiting biosynthesis of the cell wall component CGL.

Authors:  Junichi Kobayashi; Masatomo Kawakubo; Chifumi Fujii; Nobuhiko Arisaka; Masaki Miyashita; Yoshiko Sato; Hitomi Komura; Hisanori Matoba; Jun Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-20       Impact factor: 11.205

Review 5.  Interactions between Nod-Like Receptors and Intestinal Bacteria.

Authors:  Marcel R de Zoete; Richard A Flavell
Journal:  Front Immunol       Date:  2013-12-17       Impact factor: 7.561

Review 6.  Pattern-recognition receptors and gastric cancer.

Authors:  Natalia Castaño-Rodríguez; Nadeem O Kaakoush; Hazel M Mitchell
Journal:  Front Immunol       Date:  2014-07-22       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.